LAUREN PEEK TRAVILLION: Open Payments
NPI 1639645658 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 12 payments from 9 companies in 2025. Trend: 2023 $872 · 2024 $483 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
| Viatris Specialty LLC | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: QULIPTA, CAPLYTA, TRELEGY ELLIPTA, Dexcom G6 Transmitter, NURTEC ODT, YUPELRI, Symbravo, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
